Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 1
2005 3
2006 2
2008 3
2009 8
2010 7
2011 7
2012 5
2013 8
2014 4
2015 11
2016 9
2017 9
2018 8
2019 8
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

89 results
Results by year
Filters applied: . Clear all
Page 1
HTLV-1-associated myelopathy/tropical spastic paraparesis.
Bangham CR, Araujo A, Yamano Y, Taylor GP. Bangham CR, et al. Among authors: Yamano Y. Nat Rev Dis Primers. 2015 Jun 18;1:15012. doi: 10.1038/nrdp.2015.12. Nat Rev Dis Primers. 2015. PMID: 27188208 Review.
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Sato T, et al. Among authors: Yamano Y. N Engl J Med. 2018 Feb 8;378(6):529-538. doi: 10.1056/NEJMoa1704827. N Engl J Med. 2018. PMID: 29414279 Free article. Clinical Trial.
Reducing the global burden of HTLV-1 infection: An agenda for research and action.
Willems L, Hasegawa H, Accolla R, Bangham C, Bazarbachi A, Bertazzoni U, Carneiro-Proietti AB, Cheng H, Chieco-Bianchi L, Ciminale V, Coelho-Dos-Reis J, Esparza J, Gallo RC, Gessain A, Gotuzzo E, Hall W, Harford J, Hermine O, Jacobson S, Macchi B, Macpherson C, Mahieux R, Matsuoka M, Murphy E, Peloponese JM, Simon V, Tagaya Y, Taylor GP, Watanabe T, Yamano Y. Willems L, et al. Among authors: Yamano Y. Antiviral Res. 2017 Jan;137:41-48. doi: 10.1016/j.antiviral.2016.10.015. Epub 2016 Nov 11. Antiviral Res. 2017. PMID: 27840202 Free article. Review.
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach.
Katsuya H, Islam S, Tan BJY, Ito J, Miyazato P, Matsuo M, Inada Y, Iwase SC, Uchiyama Y, Hata H, Sato T, Yagishita N, Araya N, Ueno T, Nosaka K, Tokunaga M, Yamagishi M, Watanabe T, Uchimaru K, Fujisawa JI, Utsunomiya A, Yamano Y, Satou Y. Katsuya H, et al. Among authors: Yamano Y. Cell Rep. 2019 Oct 15;29(3):724-735.e4. doi: 10.1016/j.celrep.2019.09.016. Cell Rep. 2019. PMID: 31618639 Free article.
Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan.
Kuramitsu M, Okuma K, Nakashima M, Sato T, Sasaki D, Hasegawa H, Umeki K, Kubota R, Sasada K, Sobata R, Matsumoto C, Kaneko N, Tezuka K, Matsuoka S, Utsunomiya A, Koh KR, Ogata M, Ishitsuka K, Taki M, Nosaka K, Uchimaru K, Iwanaga M, Sagara Y, Yamano Y, Okayama A, Miura K, Satake M, Saito S, Watanabe T, Hamaguchi I. Kuramitsu M, et al. Among authors: Yamano Y. Microbiol Immunol. 2018 Oct;62(10):673-676. doi: 10.1111/1348-0421.12644. Microbiol Immunol. 2018. PMID: 30125970 Free article.
Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity.
Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y. Sato T, et al. Among authors: Yamano Y. Front Microbiol. 2018 Jul 25;9:1651. doi: 10.3389/fmicb.2018.01651. eCollection 2018. Front Microbiol. 2018. PMID: 30090093 Free PMC article.
Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics.
Shimizu J, Yamano Y, Kawahata K, Suzuki N. Shimizu J, et al. Among authors: Yamano Y. Medicine (Baltimore). 2018 Oct;97(42):e12837. doi: 10.1097/MD.0000000000012837. Medicine (Baltimore). 2018. PMID: 30334986 Free PMC article. Clinical Trial.
The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
Kawano N, Yoshida S, Kawano S, Kuriyama T, Tahara Y, Toyofuku A, Manabe T, Doi A, Terasaka S, Yamashita K, Ueda Y, Ochiai H, Marutsuka K, Yamano Y, Shimoda K, Kikuchi I. Kawano N, et al. Among authors: Yamano Y. J Clin Exp Hematop. 2018 Sep 19;58(3):107-121. doi: 10.3960/jslrt.18011. Epub 2018 Aug 8. J Clin Exp Hematop. 2018. PMID: 30089749 Free PMC article. Clinical Trial.
89 results
Jump to page
Feedback